N/A N=360 Participate While Pregnant Survey
Pregnancy
Primary: Willingness to Participate in Research While Pregnant — 319; 39; 288; 70 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=16 Acute Exercise Effects in Obese Pregnancy
Pregnancy Complications · Obesity · Pre-Eclampsia
Primary: Oral Glucose Insulin Sensitivity (OGIS) Index — 405.0; 426.0; 418.9 uU/mL
N/A N=150 Psychological Impact of Pregnancy of Unknown Location
Pregnancy of Unknown Location · Ectopic Pregnancy · Anxiety
Primary: Psychological Morbidity — 10; 10; 5; 5 score on a scale
N/A N=117 Happy Mother - Healthy Baby: Supplement Study on Biological Processes Underlying Anxiety During Pregnancy
Anxiety
Primary: Peripheral Markers of Inflammation — 17.09; 20.22; 14.79; 11.78 pg/ml
N/A N=305 Boostrix® Pregnancy Registry
Pertussis
Primary: Number of Participants With Known Pregnancy Outcomes, by Type of Pregnancy Outcomes in Women Intentionally or Unintentionally Vaccinated With Boostrix During Pregnancy…
N/A N=118 Weight Management for Improved Pregnancy Outcomes
Obesity · Pregnancy
Primary: Maternal Weight Change — 1.2; -2.6 kg
N/A N=360 Lifestyle and Pregnancy: The Clinical Effect of Lifestyle Intervention During Pregnancy in Obese Women
Maternal Obesity · Gestational Weight Gain · Obstetric Complications
Primary: Cesarean Section
N/A N=63 Predictive Value of the Active Straight Leg Raise on the Efficacy of a SJB in Posterior PGP During Pregnancy
Pelvic Girdle Pain
Primary: Change From Baseline in Functioning on the Active Straight Leg Rise (ASLR) Scale at 4 Weeks. — 4.87; 2.92 score on a scale — p=<.001
Phase 2 N=95 Smoking, Sex Hormones, and Pregnancy
Nicotine Dependence · Contraception
Primary: Change in Smoking Urges — 5.0; 5.5 score on a scale
Phase 3 N=348 To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older
SARS-CoV-2 Infection · COVID-19 · Maternal Immunization
Primary: Percentage of Maternal Participants Reporting Local Reactions Within 7 Days After Dose 1 — 2.5; 0.6; 0.6; 0 Percentage of participants
Phase 2 N=41 Progesterone for Smoking Relapse Prevention Following Delivery
Tobacco Use Disorder
Primary: Feasibility of Progesterone as a Relapse Prevention Intervention for Postpartum Women With Pre-conception Smoking: Adherence to Treatment — 84.5; 76.0 doses of medication
N/A N=70 Using Mental Imagination to Prevent Excessive Gestational Weight Gain in Overweight and Obese Pregnant Women
Obesity · Weight Gain, Maternal
Primary: Percent Change in Body Weight — 10.9; 9.6 percentage change
Phase 2 N=120 H1N1 Vaccine in Pregnant Women
Influenza
Primary: Number of Participants Reporting Solicited Subjective Local Reactions After First Vaccination — 15; 21; 26; 37 Participants
N/A N=30 The MOTHER (Mobile Technologies to Help Enhancing Regular Physical Activity) Trial for Pregnant Women
Physical Activity
Primary: Physical Activity Monitor Measured Steps — 1166.6; 1062.6; 1092.1; 804.3 step
N/A N=54 Personalized Management of Body Weight During Pregnancy
Weight Gain During Pregnancy
Primary: Count of Women Who Have Excess Gestational Weight Gain — 10; 11; 11 Participants
Phase 4 N=14 Effects of Pregnancy-associated Hormones on THC Metabolism in Women
Pregnancy Related · Cannabis Use
Primary: Dronabinol Exposure — 7.0; 5.6; 5.1; 5.0 nM*h — p=>0.05
N/A N=43 Auto-PAP Therapy For Improved Fetal Growth
Obstructive Sleep Apnea · Pregnancy
Primary: Number of Participants With Slowing of Fetal Growth by 33% or More During the Last Trimester — 8; 8 Participants — p=0.92
Phase 4 N=687 Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women
Diphtheria-Tetanus-acellular Pertussis Vaccines
Primary: Antibody Concentrations Against Pertussis Toxoid Antigen (Anti-PT), Filamentous Haemagglutinin Antigen (Anti-FHA) and Pertactin Antigen (Anti-PRN) in Cord Blood Samples…
N/A N=23 Halifax PrenaBelt Trial
Sleep · Pregnancy · Stillbirth
Primary: Percentage (%) of Sleep Time Supine — 3.5; 16.4 percentage of sleep time (%)
N/A N=15 Neuropathic Pain in Pregnancy
Pain · Pregnancy
Primary: Change From Baseline Visual Analogue Scale for Pain — -0.57; -14.4 score on a scale
N/A N=51 Sedentary Behavior Reduction in Pregnancy Intervention Study
Pregnancy Complications · Sedentary Behavior
Primary: Sedentary Time — 10.42; 10.52; 9.62; 10.38 total hours/day — p=<0.05
N/A N=36 Rebif® Pregnancy Registry
Multiple Sclerosis
Primary: Spontaneous Abortion — 2; 0 Participants
N/A N=2 Safety of 4CMenB Exposure During Pregnancy
Infections, Meningococcal
Primary: Major Congenital Malformation (MCM)
N/A N=113 Emotion-Diet Interactions in Pregnancy
Pregnancy Related · Stress, Psychological · Glucose Intolerance During Pregnancy
Primary: Postprandial Glycemic Response With Stress Exposure — 12998.83; 12833.69 mg/dl * minutes
Phase 2 N=370 S. Japonicum and Pregnancy Outcomes
Schistosomiasis
Primary: Mean Newborn Birth Weight — 2.85; 2.85 kilograms — p=0.988
N/A N=36 Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition
Postpartum Depression
Primary: Blood-oxygen-level-dependent (BOLD) Response During Functional Magnetic Resonance Imaging (fMRI) z Statistic — 2.3; 2.0; 2.1; 1.7 z score — p=.27
Phase 2 N=47 Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects
Nutrient Deficiency · Pregnancy Related
Primary: Change in Maternal Macular Carotenoid Levels From Enrollment to Birth of Infant — 12244; 7343 unitless
N/A N=46 Progesterone & Postpartum Relapse to Smoking
Tobacco Use Cessation · Tobacco Use Disorder
Primary: Number of Participants Who Relapsed by Week 4 Postpartum — 6; 7 participants
N/A N=140 Physical Activity in Pregnancy and Postpartum Period, Effects on Women
Pregnancy
Primary: Delivery Times Measured in Partogram — 389.33; 561.3 minutes — p=0.776
N/A N=120 Monitoring Movement and Health Study
Pregnancy Related · Obesity · Hypertension
Primary: Number of Participants Classified as Having High Sedentary Behavior (by Trajectory) — 45 Participants